Oncogenic drivers of GIST are mainly a range of primary gain-of-function mutations in KIT and PDGFRA. 2Concomitant mutations in other kinases are uncommon, thus highlighting the role of the KIT/PDGFRA transforming program in GIST. Here, KIT is linked to gastrointestinal stromal tumor.